Patient Forum: Action-Oriented Discussion to Increase Diversity in Clinical Trials brought to you by Pfizer

Chair(s)

• 

  Stephani Stancil, PhD (she/her/hers)

  Assistant Professor
  Children's Mercy Kansas City

Speaker(s)

• 

  Ricki Fairley, MBA (she/her/hers)

  CEO
  Touch, The Black Breast Cancer Alliance
• 

  LaToya T. Bolds-Johnson, MS (she/her/hers)

  Breast Cancer Survivor-Advocate, Physician Assistant
  Touch, The Black Breast Cancer Alliance
• 

  Hope Krebill, RN (she/her/hers)

  Executive Director, Masonic Cancer Alliance, Assistant Director, Community Outreach, The University of Kansas Cancer Center
  The University of Kansas Cancer Center
• 

  Barbara E. Bierer, MD (she/her/hers)

  Professor of Medicine, Faculty Director, MRCT Center
  Harvard Medical School/

Clinical trials are a vital tool to bring innovative drug discovery to individual patients. Clinical trial enrollment is a key driver for clinical trial success. And diversity in clinical trial enrollment can be the difference between effective medications for a subset of the global population or effective medications for all.

This session will feature leading change-makers dedicated to ensuring individuals have access to state-of-the-art treatments to live their full lives despite life-altering diagnoses. Speakers will share their experience receiving transformative medications through participation in clinical trials and their call to increase access to clinical trials for all.

The audience will leave with action steps and examples of patient-informed clinical trials that ultimately improve participant diversity, enrollment success, and treatment outcomes for historically marginalized patients.

The leaders shaping the future of clinical trials will be in this room. Will you be part of the conversation?

Secure Your Spot Now!

Brought to you by:

This event is sponsored by an ASCPT Partner organization. ASCPT partners were not involved in the development or content of this program.